<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 07 May 2021 21:36:38 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Aβ抗体开发迎来转机？Nature揭示改善阿尔茨海默症治疗关键途径</title><link>https://mp.weixin.qq.com/s/K9tQEjpKlYL2TGrbmDoHqg</link><description></description><content:encoded><![CDATA[Aβ抗体开发迎来转机？Nature揭示改善阿尔茨海默症治疗关键途径]]></content:encoded><pubDate>Fri, 07 May 2021 21:04:42 +0800</pubDate></item><item><title>多项授权合作，Synaffix公司ADC专利技术解析</title><link>https://mp.weixin.qq.com/s/uUcZ8UFGuJak3qDeFYw5Fg</link><description></description><content:encoded><![CDATA[多项授权合作，Synaffix公司ADC专利技术解析]]></content:encoded><pubDate>Thu, 06 May 2021 20:59:30 +0800</pubDate></item><item><title>PROTAC“变”分子胶：MDM2降解剂，竟能降解p53？</title><link>https://mp.weixin.qq.com/s/6uk4HUB0fXmC8BeX9aHCLg</link><description></description><content:encoded><![CDATA[PROTAC“变”分子胶：MDM2降解剂，竟能降解p53？]]></content:encoded><pubDate>Wed, 05 May 2021 21:04:11 +0800</pubDate></item><item><title>PD-L1抗体“新搭档”——HDAC8抑制剂 | Science子刊发表肝癌治疗突破</title><link>https://mp.weixin.qq.com/s/i1Y65Q0Gg9yIIOgqXON4ZQ</link><description></description><content:encoded><![CDATA[PD-L1抗体“新搭档”——HDAC8抑制剂 | Science子刊发表肝癌治疗突破]]></content:encoded><pubDate>Tue, 04 May 2021 20:59:53 +0800</pubDate></item><item><title>Cell重磅：新型髓系细胞疗法来了！有效抗转移，联合化疗实现癌症小鼠持久治愈</title><link>https://mp.weixin.qq.com/s/0zcQVs_oSYIBF8DeLXUQ3w</link><description></description><content:encoded><![CDATA[Cell重磅：新型髓系细胞疗法来了！有效抗转移，联合化疗实现癌症小鼠持久治愈]]></content:encoded><pubDate>Mon, 03 May 2021 21:00:12 +0800</pubDate></item><item><title>开发抗衰老mRNA疗法！ 初创公司Turn完成新一轮融资，开启新一代表观基因组重编程</title><link>https://mp.weixin.qq.com/s/b1L-XH92_4t7wOFqgqb3aA</link><description></description><content:encoded><![CDATA[开发抗衰老mRNA疗法！ 初创公司Turn完成新一轮融资，开启新一代表观基因组重编程]]></content:encoded><pubDate>Sun, 02 May 2021 21:00:36 +0800</pubDate></item><item><title>压力太大，秃如其来？Nature：有救了！</title><link>https://mp.weixin.qq.com/s/fApgv4W18ws2mYOVwQ_WTg</link><description></description><content:encoded><![CDATA[压力太大，秃如其来？Nature：有救了！]]></content:encoded><pubDate>Sat, 01 May 2021 21:01:04 +0800</pubDate></item><item><title>PARP抑制剂“新搭档”——DNPH1抑制剂 | Science里程碑</title><link>https://mp.weixin.qq.com/s/S_I0VIU-nbUDK8iCyzl6Yw</link><description></description><content:encoded><![CDATA[PARP抑制剂“新搭档”——DNPH1抑制剂 | Science里程碑]]></content:encoded><pubDate>Fri, 30 Apr 2021 21:17:35 +0800</pubDate></item><item><title>攻克实体瘤，CAR-T有戏了 | Science子刊封面论文</title><link>https://mp.weixin.qq.com/s/ucP8pXAAUOE3m8Fl5K_klg</link><description></description><content:encoded><![CDATA[攻克实体瘤，CAR-T有戏了 | Science子刊封面论文]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:00:26 +0800</pubDate></item><item><title>Nature里程碑：肿瘤新靶点METTL3，潜在first-in-class白血病新药显现</title><link>https://mp.weixin.qq.com/s/AevrqaDBm-MHzWUhxcjsLA</link><description></description><content:encoded><![CDATA[Nature里程碑：肿瘤新靶点METTL3，潜在first-in-class白血病新药显现]]></content:encoded><pubDate>Wed, 28 Apr 2021 20:58:18 +0800</pubDate></item></channel></rss>